BCL2 and diffuse large B-cell lymphoma: Regarding the effect of other biological parameters in patients with bulky mass DLBCL, this study found that the MYC/BCL2 DE status failed to confer a significant prognostic difference in OS and PFS, contrary to several studies of an entire DLBCL cohort.5, 6, 7, 8, 9